Quick Takeaways
- Lind Global Fund III LP filed SCHEDULE 13G for Bionano Genomics, Inc. Common Stock, $0.0001 par value per share (BNGO).
- Disclosed ownership: 9.9%.
- Date of event: 17 Sep 2025.
Lind Global Fund III LP - 17 Sep 2025 SCHEDULE 13G Report for Bionano Genomics, Inc. Common Stock, $0.0001 par value per share (BNGO)
- Filing Manager
- Lind Global Fund III LP
- Reporting Manager
- Lind Global Fund III LP
- Symbol
- BNGO
- Shares outstanding
- 10,161,222 shares
- Disclosed Ownership
- 1,005,961 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 24 Sep 2025, 20:00:16 UTC
- Date of event
- 17 Sep 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Lind Global Fund III LP disclosed 9.9% ownership in Bionano Genomics, Inc. Common Stock, $0.0001 par value per share (BNGO) on 17 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 24 Sep 2025, 20:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Lind Global Fund III LP | 9.9% | 1,005,961 | 1,005,961 | 0 | By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton | Jeff Easton, Managing Member | |
| Lind Global Partners III LLC | 9.9% | 1,005,961 | 1,005,961 | 0 | /s/ Jeff Easton | Jeff Easton, Managing Member | |
| Jeff Easton | 9.9% | 1,005,961 | 1,005,961 | 0 | /s/ Jeff Easton | Jeff Easton |